Supplementary Files
Keywords
Poor Response
Metformin, Glycemic Control
Insulin Therapy
How to Cite
Abstract
Objective: The primary aim of this investigation was to determine the incidence of patients transitioning from metformin monotherapy to a combined regimen of insulin and metformin during the second or third trimester of pregnancy for managing gestational diabetes.
Methods: This was a descriptive cross-sectional study conducted in the Department of Obstetrics and Gynecology at DHQ Hospital, Rawalpindi, from May 11, 2021, to May 10, 2022.
This analysis involved 246 pregnant women aged between 20 and 35 years diagnosed with GDM during the first or second trimester of pregnancy and taking metformin mono-therapy. These women were followed, and a poor response to metformin was labeled as the need for supplemental insulin during the 2nd or 3rd trimester.
Results: The mean age of the women was 26.6±4.6 years. The mean BMI of these women was 26.8±4.5 Kg/m2, and 43.5% of women were obese. Family history of diabetes was positive in 46.7% of women, while 28.0% of women had a history of GDM in a previous pregnancy. Poor response to metformin therapy was noted in 45 (18.3 %) women with GDM. Upon comparison, it was observed that the incidence of advanced maternal age (≥30 years) (53.3% vs. 23.4%; p-value<0.001), early onset of gestational diabetes mellitus (GDM) (gestational age ≤15 weeks) (77.8% vs. 46.8%; p-value<0.001), and obesity (62.2% vs. 39.3%; p-value=0.005) exhibited a statistically significant elevation among individuals with an inadequate response to metformin therapy, necessitating the inclusion of supplemental insulin.
Conclusion: In the current study, we observed that a considerable proportion of pregnant women with GDM had poor response to metformin, and the frequency of older maternal age, early onset of GDM, and obesity was significantly higher among such cases, advocating that such women should be considered at higher risk of failure of metformin mono-therapy.
Keywords: Gestational Diabetes, Metformin, Insulin, Treatment Outcome, Blood Glucose
References
Souza ML, Silva RR, Silva TR, Oliveira LC, Dienstmann G, Nascimento IB, et al. Factors associated with the need for insulin as a complementary treatment to metformin in gestational diabetes mellitus. Revista Brasileira de Ginecologia e Obstetrícia 2020;41:697-702. https://doi.org/10.1055/s-0039-1700796
Benhalima P, Lens O, Bosteels K, Chantal I. The risk for glucose intolerance after gestational diabetes mellitus since the introduction of the IADPSG criteria: a systematic review and meta-analysis.Journal of Clinical Medicine 2019;8(9):1431.https://doi.org/10.3390/jcm8091431
Scholtens DM, Kuang A, Lowe LP. Hyperglycemia and adverse pregnancy outcome follow-up study (HAPO FUS): maternal glycemia and childhood glucose metabolism. Diabetes Care 2019;42(7):e127.https://doi.org/10.2337/dc18-2021
Stacey T, Tennant P. Authors' reply re: gestational diabetes and the risk of late stillbirth: a case control study from England, UK. British Journal of Obstetrics & Gynacology 2019;126(9):1184. https://doi.org/10.1111/1471-0528.15659
Urbanov J, Brunerov L, Nunes M, Bro J. Identification of MODY among patients screened for gestational diabetes: a clinician’s guide. Archives of Gynecology & Obstetrics 2020;302(2):305-14. https://doi.org/10.1007/s00404-020-05626-y
Mijatovic J, Louie JC, Buso ME, Atkinson FS, Ross GP, Markovic TP, et al. Effects of a modestly lower carbohydrate diet in gestational diabetes: a randomized controlled trial. The American Journal of Clinical Nutrition 2020;112(2):284-92. https://doi.org/10.1093/ajcn/nqaa137
Chaves C, Cunha F, Martinho M, Garrido S, Silva-vieira M, Estevinho C, et al. Metformin combined with insulin in women with gestational diabetes mellitus: a propensity score-matched study. Acta Diabetologica 2021;58(5):615-21. https://doi.org/10.1007/s00592-020-01665-8
Abell SK, Boyle JA, Earnest A, England P, Nankervis A, Ranasinha S, et al. Impact of different glycaemic treatment targets on pregnancy outcomes in gestational diabetes. Diabetic Medicine 2019;36(2):177-83. https://doi.org/10.1111/dme.13799
Mclean A, Katz M, Oats J, Wang Z, Barr E, Maplebrown L, et al. Rethinking third-trimester ultrasound measurements and risk of adverse neonatal outcomes in pregnancies complicated by hyperglycaemia: a retrospective study.The Australian & NewZealand Journal of Obstetrics & Gynaecology 2021;61(3):366-72. https://doi.org/10.1111/ajo.13281
Yu Y, Arah OA, Liew Z, Cnattingius S, Olsen J, Srensen HT, et al. Maternal diabetes during pregnancy and early onset of cardiovascular disease in offspring: population based cohort study with 40 years of follow-up. British Medical Jornal 2019;12(4):l6398. https://doi.org/10.1136/bmj.l6398
Powe CE, Presley L, Locascio JJ, Catalano P. Augmented insulin secretory response in early pregnancy is independent of gestational insulin resistance. Diabetologia 2019;68(Suppl-1):82-9. https://doi.org/10.1007/s00125-019-4881-6.
Li-zhen L, Yun X, Xiao-dong Z, Shu-bin H, Zi-lian W, Adrian sandra D, et al. Evaluation of guidelines on the screening and diagnosis of gestational diabetes mellitus: systematic review.British Medical Journal Open 2019;9(5):e023014. https://doi.org/10.1136/bmjopen-2018-023014
Kousar R, Islam F, Raza A, Imtiaz S. Prevalence and related risk factors of diabetes mellitus among multigravida females with the history of gestational diabetes mellitus; a retrospective cross-sectional study. Pak-Euro Journal of Medical & Life Sciences 2022;5(2):267-74.DOI: https://doi.org/10.31580/pjmls.v5i2.2515
Riaz M, Nawaz A, Masood SN, Fawwad A, Basit A, Shera AS. Frequency of gestational diabetes mellitus using DIPSI criteria, a study from Pakistan. Clinical Epidemiology & Global Health 2019;7(2):218-21. https://doi.org/10.1016/j.cegh.2018.06.003
Wali AS, Raique R, Iftikhar S, Ambreen R, Yakoob MY. High proportion of overt diabetes mellitus in pregnancy and missed opportunity for early detection of diabetes at a tertiary care centre in Pakistan. Pakistan Journal of Medical Sciences 2020;36(1):S38-43. https://doi.org/10.12669/pjms.36.ICON-Suppl.1723
Chebrolu P, Kurbude R, Thakur M, Shah N, Jain R. Gestational diabetes in rural central India: low prevalence but absence of typical risk factors. Heliyon 2021;7(7):e07431. https://doi.org/10.1016/j.heliyon.2021.e07431
Rafiq J, Karim F, Jamal MM, Chattha MN. Maternal and perinatal outcome in mothers with gestational diabetes mellitus in Combined Military Hospital Sialkot. Journal of Society of Obstetricians & Gynaecologist Pakistan 2019;9(2):88-92.
Bahl S, Dhabhai N, Taneja S, Mittal P, Dewan R, Kaur J, et al. Burden, risk factors and outcomes associated with gestational diabetes in a population-based cohort of pregnant women from North India. BioMedCentral Pregnancy Childbirth 2022;22(1):1-6. https://doi.org/10.1186/s12884-022-04389-5
Khattak SN, Shah AH, Imran A, Khattak MI, Mansoor K, Memon AN. Outcomes of gestational diabetes mellitus in Pakistani mothers: an experience of a tertiary care hospital. Journal of Bahria University Medical & Dental College 2021;11(4):174-8.DOI: https://doi.org/10.51985/JBUMDC2021050
Chanda S, Dogra V, Hazarika N, Bambrah H, Sudke AK, Vig A, et al. Prevalence and predictors of gestational diabetes mellitus in rural Assam: a cross-sectional study using mobile medical units. British Medical Journal Open 2020;10(11):e037836. https://doi.org/10.1136/bmjopen-2020-037836
Silva VB, Fonseca L, Pereira MT, Vilaverde J, Pinto C, Pichel F, et al. Predictors of metformin mono-therapy failure in gestational diabetes mellitus. Endocrine Connections 2022;11(5):e210540. https://doi.org/10.1530/EC-21-0540
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Copyright (c) 2026 Seher Iftikhar, Sobia Nawaz, Shazia Syed, Fizza Fatima, Saima Bibi, Sara Malik